Credit: Unsplash/CC0 Public Domain Semaglutide (brand name: Wegovy) has the potential to markedly reduce the risk of heart attacks and other heart-related conditions among millions of Americans with obesity who have also been diagnosed with cardiovascular disease, a Yale study shows. The research was based on the Semaglutide Effects on Cardiovascular Outcomes in People With […]
The authors found that presenting with at least one food sensitivity was associated with a higher risk of death from cardiovascular causes in both the NHANES and MESA groups. This association was the strongest among participants who were sensitive to milk. In addition, according to the NHANES data, “consumption was an important modifier of cardiovascular […]
November 22, 2023 — Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced the closing of its license agreements with the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai), in New York, NY, to develop and […]
Grants and Awards By: Damian McNamara | November 22, 2023 | 4 min. read | Share Article Summary Gold Plus distinction is awarded to health care organizations that attest to at least four of six evidence-based blood pressure activities. The Comprehensive Hypertension Center is responding to an urgent need in the U.S., where half of the […]
WEDNESDAY, Nov. 22, 2023 (HealthDay News) — For patients treated with peritoneal dialysis (PD), mean platelet volume (MPV) is associated with all-cause mortality and cardiovascular mortality, according to a study published online Nov. 8 in BMC Cardiovascular Disorders. Jianghai Wang, from the Dongying People’s Hospital in China, and colleagues estimated the relationship between MPV and […]
WEDNESDAY, Nov. 22, 2023 (HealthDay News) — Sleep-related hypoxia is associated with incident atrial fibrillation (AF), according to a study published online Nov. 10 in the Journal of the American Heart Association. Catherine M. Heinzinger, D.O., from the Cleveland Clinic, and colleagues examined the association between sleep-disordered breathing, hypoxia, and pulmonary physiology on atrial fibrillation. The […]
Los fármacos contra el trastorno por déficit de atención e hiperactividad (TDAH) aumentan el riesgo de sufrir enfermedades cardiovasculares, según el mayor estudio sobre los efectos de este tipo de medicación a largo plazo. Los resultados muestran que solo una minoría de las personas que se medican contra el TDAH desarrollan problemas cardiovasculares. Los autores […]
CNN — Long-term use of ADHD medications can raise the risk of cardiovascular disease in both children and adults, according to a study published Wednesday in JAMA Psychiatry. Experts say that the benefits of treatment still outweigh the risks for many, but heart heath should be carefully considered and monitored when making individual decisions. Researchers […]
Deidre McPhillips, CNN November 22, 2023 at 11:00 AM Viktoriya Skorikova/Moment RF/Getty Images Long-term use of ADHD medications can raise the risk of cardiovascular disease in both children and adults, according to a study published Wednesday in JAMA Psychiatry. Experts say that the benefits of treatment still outweigh the risks for many, but heart heath […]
Credit: SIphotography/Getty Images Results from a large study carried out in Sweden show that long-term use of attention-deficit/hyperactivity disorder (ADHD) medication can increase cardiovascular disease (CVD) risk. Zheng Chang, a group leader at the Karolinska Institutet in Stockholm, and colleagues found that for every year of ADHD medication use CVD risk increased by four percent. […]